Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Consolidated Net Income (2022 - 2024)

Moolec Science (MLECW) posted Consolidated Net Income of -$3.3 million for Q4 2024, down 68.74% sequentially from -$2.0 million in Q3 2024, and down 156.61% YoY from $5.9 million in Q1 2024.

Moolec Science (MLECW) Consolidated Net Income (2022 - 2024) Analysis & Trends

Moolec Science has reported Consolidated Net Income for 3 years, with the latest figure at -$3.3 million in Q4 2024.

  • Quarterly Consolidated Net Income fell 156.61% year-over-year to -$3.3 million in Q4 2024, while the trailing twelve-month figure through Mar 2026 was -$3.3 million (changed N/A YoY) and the FY2024 annual result came in at -$6.2 million, up 88.53% from the prior year.
  • Consolidated Net Income fell to -$3.3 million in Q4 2024 per MLECW's latest filing, from -$2.0 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $48.0 million in Q4 2022 and troughed at -$3.3 million in Q4 2024.
  • A 3-year average of $3.1 million and a median of -$1.3 million in 2022 frame the typical range for Consolidated Net Income.
  • The sharpest annual moves came in 2023 and 2024: Consolidated Net Income surged 69.28% in 2023, then tumbled 220.25% in 2024.
  • Over 3 years, Consolidated Net Income stood at $48.0 million in 2022, then plunged by 87.75% to $5.9 million in 2023, then sank by 156.61% to -$3.3 million in 2024.
  • According to Business Quant data, Consolidated Net Income over the past three periods registered -$3.3 million, -$2.0 million, and -$1.8 million for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 482.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -174.37 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -13.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Moolec Science 8,617.72 -1.19 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -3.33 Mn
Sep 30, 2024 -1.97 Mn
Jun 30, 2024 -1.83 Mn
Mar 31, 2024 -1.15 Mn
Dec 31, 2023 5.88 Mn
Sep 30, 2023 -1.81 Mn
Jun 30, 2023 -2.98 Mn
Mar 31, 2023 -358,578.00
Dec 31, 2022 47.96 Mn
Sep 30, 2022 -721,426.00
Jun 30, 2022 -1.52 Mn
Mar 31, 2022 -1.17 Mn